MAVACAMTEN: A door that has opened in the treatment of Hyper-trophic Cardiomyopathy

Authors

  • Ishaque Hameed Department of Internal Medicine, Dow University of Health and Sciences, Civil Hospital, Karachi, Pakistan
  • Omer Mustafa Siddiqui Department of Internal Medicine, Dow University of Health and Sciences, Civil Hospital, Karachi, Pakistan
  • Syed Abdus Samad Department of General Surgery, Dow University of Health and Sciences, Civil Hospital, Karachi, Pakistan

DOI:

https://doi.org/10.47391/JPMA.7258

Abstract

Not Applicable.

Downloads

Published

2023-02-15

How to Cite

Hameed , I., Siddiqui, O. M., & Samad, S. A. (2023). MAVACAMTEN: A door that has opened in the treatment of Hyper-trophic Cardiomyopathy. Journal of the Pakistan Medical Association, 73(2), 446–447. https://doi.org/10.47391/JPMA.7258

Issue

Vol. 73 No. 2 (2023): February

Section

Letter to the Editor